David Shaw’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

David Shaw’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-176,831	Closed	-$8.12M	–	4042
2015 Q1	$8.12M	Buy	176,831 +6,104	+4%	+$183K	0.01%	1085
2014 Q4	$4.1M	Buy	170,727 +75,296	+79%	+$1.7M	0.01%	1718
2014 Q3	$2.41M	Buy	95,431 +41,399	+77%	+$1.03M	﹤0.01%	2096
2014 Q2	$1.41M	Buy	54,032 +20,812	+63%	+$535K	﹤0.01%	2616
2014 Q1	$857K	Buy	+33,220	New	+$900K	﹤0.01%	3165

David Shaw's HPTX Position: Q2 2015 in Review

David Shaw sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 176,831 shares — an estimated $8.12M sold.

David Shaw first reported a position in HPTX in Q1 2014 and held it in 5 quarters. The position peaked at $8.12M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

David Shaw reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
David Shaw sold 176,831 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $8.12M.
David Shaw first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
David Shaw's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $8.12M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.